- Home
- ANIK
as 03-28-2025 3:30pm EST
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | BEDFORD |
| Market Cap: | 243.4M | IPO Year: | 1993 |
| Target Price: | $22.00 | AVG Volume (30 days): | 89.0K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.95 - $29.12 | Next Earning Date: | 03-12-2025 |
| Revenue: | $119,907,000 | Revenue Growth: | -0.73% |
| Revenue Growth (this year): | -2.6% | Revenue Growth (next year): | 8.50% |
Latest Anika Therapeutics Inc. News
ANIK Breaking Stock News: Dive into ANIK Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 days ago
Anika Therapeutics Full Year 2024 Earnings: Misses Expectations
Thomson Reuters StreetEvents
16 days ago
Q4 2024 Anika Therapeutics Inc Earnings Call
GuruFocus.com
16 days ago
Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges
Zacks
17 days ago
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates
MT Newswires
17 days ago
Anika Therapeutics Q4 Swings to Adjusted Loss, Revenue Rises -- Shares Drop After Hours
Associated Press Finance
17 days ago
Anika: Q4 Earnings Snapshot
GlobeNewswire
17 days ago
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
MT Newswires
22 days ago
Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta
Compare ANIK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ANIK Anika Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.